Thiophene substituted amine derivatives as GLYT-1 inhibitors

Details for Australian Patent Application No. 2002235682 (hide)

Owner NPS Allelix Corp. Allelix Neuroscience, Inc.

Inventors Hopper, Allen T.; Maddaford, Shawn; Wang, Zhaoqing; Egle, Ian; Schumacher, Richard; Tehim, Ashok; Delaney, William

Agent Davies Collison Cave

Pub. Number AU-B-2002235682

PCT Pub. Number WO2002/066456

Priority 60/269,241 16.02.01 US

Filing date 15 February 2002

Wipo publication date 4 September 2002

Acceptance publication date 26 April 2007

International Classifications

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07B 61/00 (2006.01) Other general methods

C07C 33/48 (2006.01) Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms

C07C 229/14 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 409/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-B-2002235682

4 August 2005 Amendment Made

  The nature of the amendment is: Amend co-inventor from Shumacher, Richard to Schumacher, Richard

26 April 2007 Application Accepted

  Published as AU-B-2002235682

23 August 2007 Standard Patent Sealed

31 July 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 May 2007. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

6 November 2008 Assignment Registered

  Allelix Neuroscience, Inc.; NPS Allelix Corp. The patent has been assigned to NPS Pharmaceuticals, Inc.

11 December 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 May 2007

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002235683-METHOD FOR OBTAINING A LITHOGRAPHIC PRINTING SURFACE USING AN ORGANIC BASE

2002235681-PRODUCTION OF HIGH STRENGTH ALUMINUM ALLOY FOILS